95 results on '"Ravizza, Luigi"'
Search Results
2. Stress and managerial work: organizational culture and technological changes: a clinical study
3. Recognition and Treatment of Dysthymia in Elderly Patients
4. Long Term Treatment of Obsessive-Compulsive Disorder
5. Altered cAMP-Dependent Protein Kinase A in Platelets of Patients With Obsessive-Compulsive Disorder
6. Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease
7. The cAMP-dependent protein kinase substrate Rap1 in platelets from patients with obsessive compulsive disorder or schizophrenia
8. Lymphocyte peripheral benzodiazepine receptor mRNA decreases in obsessive-compulsive disorder
9. Recent life events and obsessive–compulsive disorder (OCD): the role of pregnancy/delivery
10. Sindrome metabolica e patologie correlate nella schizofrenia. Linee guida per il monitoraggio medico
11. I predittori di resistenza al trattamento farmacologico dl disturbo ossessivo-compulsivo
12. La diversa espressività clinica del disturbo ossessivo-compulsivo in relazione al genere
13. Axis II comorbidity in early- versus late-onset obsessive-compulsive disorder
14. Elementi clinici premorbosi e esordio del disturbo ossessivo-compulsivo
15. Il disturbo ossessivo-compulsivo in gravidanza e nel postpartum
16. Disturbo ossessivo-compulsivo: differenze in relazione al genere
17. Quadri clinici di disturbo ossessivo-compulsivo indotti da sostanze o secondari a condizioni mediche generali
18. Il disturbo ossessivo-compulsivo. Terapia
19. Il disturbo ossessivo-compulsivo. Aspetti psicopatologici
20. Il disturbo ossessivo-compulsivo. Epidemiologia e clinica
21. Fattori predittivi di deterioramento nel disturbo ossessivo-compulsivo
22. Il disturbo ossessivo-compulsivo e i disturbi di personalità
23. Il problema del disturbo d'ansia generalizzato
24. Associazione farmacologica nella terapia della schizofrenia con particolare riferimento al ruolo attuale dei farmaci antidepressivi
25. La depressione atipica
26. Disturbi di personalità e disturbo ossessivo compulsivo: analisi critica dei dati della letteratura e delle nostre ricerche
27. La terapia farmacologica del disturbo ossessivo-compulsivo
28. Il disturbo ossessivo-compulsivo: aspetti clinico-nosografici
29. Predictors of response and long-term treatment of obsessive compulsive disorder
30. Terapia farmacologica del disturbo ossessivo-compulsivo: rapporto tra risposta clinica, livello plasmatico del farmaco e sistemi monoaminergici
31. Consensus on the Use of Substituted Benzamides in Psychiatric Patients
32. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression
33. A comparison of paroxetine and amisulpride in the treatment of dysthymic disorder
34. An Exploratory Study on Obsessive-Compulsive Disorder with and without a Familial Component: Are There Any Phenomenological Differences?
35. Paroxetine versus amitriptyline in patients with recurrent major depression: A double-blind trial
36. Bulimia nervosa with and without obsessive-compulsive syndromes
37. The Role of Recent Life Events in the Onset of Obsessive-Compulsive Disorder
38. Onset of Obsessive-Compulsive Disorder: Premorbid Conditions and Prodromal Phase
39. SUICIDE AND DEPRESSION
40. Peripheral benzodiazepine receptor messenger RNA is decreased in lymphocytes of generalized anxiety disorder patients
41. Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa
42. An open-label, randomized, prospective comparison of sertraline and amisulpride in the treatment of dysthymia in the elderly
43. Clinical Features of Lewy Body Dementia
44. Episodic and chronic obsessive-compulsive disorder
45. Invecchiamento cerebrale e demenze
46. Type I and type II schizophrenia: relations between tonic electrodermal activity and clinical ratings before and after haloperidol treatment
47. PD 1001: A Wide Range of Treatments and Possibilities in Future Clinical Applications
48. AN ANALYSIS OF LYMPHOCYTE3H-N-METHYL-SCOPOLAMINE BINDING IN NEUROLOGICAL PATIENTS
49. Amisulpride in medium-term treatment of dysthymia: a six-month, double-blind safety study versus amitriptyline. AMILONG investigators.
50. Contributions cliniques et biochimiques sur l'action de la maprotiline et de la clomipramine dans les états dépressifs.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.